{"groups":[{"description":"Cancer patients treated with chemotherapy and who are prescribed commercially available filgrastim biosimilar for primary or secondary prophylaxis for FN.","id":"FG000","title":"EP2006"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"1496"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"828"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"668"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}